Notice of Updates – FDA Recognized Antimicrobial Susceptibility Test Interpretive Criteria
FDA has updated the STIC website with breakpoint information for the following:
Antibacterial Susceptibility Test Interpretive Criteria
https://www.fda.gov/drugs/development-resources/antibacterial-susceptibility-test-interpretive-criteria
Notices of Updates
https://www.fda.gov/drugs/development-resources/notices-updates
FDA Rationale for Breakpoints Recognition Decision: Polymyxins and Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp.
https://www.fda.gov/drugs/development-resources/fda-rationale-breakpoints-recognition-decision-polymyxins-and-enterobacterales-pseudomonas
Azithromycin - Oral, Injection products
https://www.fda.gov/drugs/development-resources/azithromycin-oral-injection-products
Cefazolin – Injection products
https://www.fda.gov/drugs/development-resources/cefazolin-injection-products
Cefepime – Injection products
https://www.fda.gov/drugs/development-resources/cefepime-injection-products
Cefoxitin - Injection products
https://www.fda.gov/drugs/development-resources/cefoxitin-injection-products
Ceftazidime – Injection products
https://www.fda.gov/drugs/development-resources/ceftazidime-injection-products
Ceftolozane Tazobactam – Injection products
https://www.fda.gov/drugs/development-resources/ceftolozane-tazobactam-injection-products
Ceftriaxone - Injection products
https://www.fda.gov/drugs/development-resources/ceftriaxone-injection-products
Cefuroxime - Injection products
https://www.fda.gov/drugs/development-resources/cefuroxime-injection-products
Chloramphenicol Injection Products
https://www.fda.gov/drugs/development-resources/chloramphenicol-injection-products
Levofloxacin Oral, Injection products
https://www.fda.gov/drugs/development-resources/levofloxacin-oral-injection-products
Meropenem - Injection products
https://www.fda.gov/drugs/development-resources/meropenem-injection-products
Minocycline Oral, Injection products
https://www.fda.gov/drugs/development-resources/minocycline-oral-injection-products
Moxifloxacin Oral, Injection Products
https://www.fda.gov/drugs/development-resources/moxifloxacin-oral-injection-products
Tetracycline – Oral products
https://www.fda.gov/drugs/development-resources/tetracycline-oral-products
Ticarcillin Clavulanate – Injection products
https://www.fda.gov/drugs/development-resources/ticarcillin-clavulanate-injection-products
Trimethoprim Sulfamethoxazole – Oral, Injection products
https://www.fda.gov/drugs/development-resources/trimethoprim-sulfamethoxazole-oral-injection-products
FDA Updates
[[Edit text]]
** If you did not subscribe to the FDA Recognized Antimicrobial STIC Breakpoints subscription you may unsubscribe from this list by clicking on the "Manage Preferences or Unsubscribe from this List" link below.
|
